Association between schizophrenia and genetic variation in DCC: A case-control study

Schizophrenia Research

Volumn 137, Issue 1-3, 2012, Pages 26-31

  Grant, Alanna ^a   Fathalli, Ferid ^b   Rouleau, Guy ^c   Joober, Ridha ^a,b   Flores, Cecilia ^a,b  

^a DOUGLAS MENTAL HEALTH UNIVERSITY INSTITUTE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Candidate gene; Development; Mesocorticolimbic dopamine system; Netrin 1

Indexed keywords

GENOMIC DNA; MESSENGER RNA;

3' UNTRANSLATED REGION; ADULT; ALLELE; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DELETED IN COLORECTAL CANCER GENE; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCATION; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECEPTOR GENE; REGULATORY SEQUENCE; RNA STABILITY; RNA TRANSLATION; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PSYCHIATRIC STATUS RATING SCALES; RECEPTORS, CELL SURFACE; SCHIZOPHRENIA; TUMOR SUPPRESSOR PROTEINS;

EID: 84860839588     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2012.02.023     Document Type: Article

References (70)

1. Abi-Dargham A., van de Giessen E., Slifstein M., Kegeles L.S., Laruelle M. Baseline and amphetamine-stimulated dopamine activity are related in drug-naive schizophrenic subjects. Biol. Psychiatry 2009, 65:1091-1093.
2. Akil M., Pierri J.N., Whitehead R.E., Edgar C.L., Mohila C., Sampson A.R., Lewis D.A. Lamina-specific alterations in the dopamine innervation of the prefrontal cortex in schizophrenic subjects. Am. J. Psychiatry 1999, 156:1580-1589.
3. Barak Y., Achiron A., Mandel M., Mirecki I., Aizenberg D. Reduced cancer incidence among patients with schizophrenia. Cancer 2005, 104:2817-2821.
4. Boksa P. Animal models of obstetric complications in relation to schizophrenia. Brain Res. Brain Res. Rev. 2004, 45:1-17.
5. Boksa P. Effects of prenatal infection on brain development and behavior: a review of findings from animal models. Brain Behav. Immun. 2010, 24:881-897.
6. Cardno A.G., Marshall E.J., Coid B., Macdonald A.M., Ribchester T.R., Davies J., Venturi P., Jones L.A., Lewis S.W., Sham P.C., Gottesman I.I., Farmer A.E., McGuffin P., Reveley A.M., Murray R.M. Heritability estimates for psychotic disorders: the Maudsley twin psychosis series. Arch. Gen. Psychiatry 1999, 56:162-168.
7. Catts V.S., Catts S.V., O'Toole B.I., Frost A.D. Cancer incidence in patients with schizophrenia and their first-degree relatives - a meta-analysis. Acta Psychiatr. Scand. 2008, 117:323-336.
8. Chen J.M., Ferec C., Cooper D.N. A systematic analysis of disease-associated variants in the 3' regulatory regions of human protein-coding genes II: the importance of mRNA secondary structure in assessing the functionality of 3' UTR variants. Hum. Genet. 2006, 120:301-333.
9. Cincotta M., Ragazzoni A., de Scisciolo G., Pinto F., Maurri S., Barontini F. Abnormal projection of corticospinal tracts in a patient with congenital mirror movements. Neurophysiol. Clin. 1994, 24:427-434.
10. Cohen M., Dembling B., Schorling J. The association between schizophrenia and cancer: a population-based mortality study. Schizophr. Res. 2002, 57:139-146.
11. Colon-Ramos D.A., Margeta M.A., Shen K. Glia promote local synaptogenesis through UNC-6 (netrin) signaling in C. elegans. Science 2007, 318:103-106.
12. Crow T.J. Temporal lobe asymmetries as the key to the etiology of schizophrenia. Schizophr. Bull. 1990, 16:433-443.
13. Crow T.J., Ball J., Bloom S.R., Brown R., Bruton C.J., Colter N., Frith C.D., Johnstone E.C., Owens D.G., Roberts G.W. Schizophrenia as an anomaly of development of cerebral asymmetry. A postmortem study and a proposal concerning the genetic basis of the disease. Arch. Gen. Psychiatry 1989, 46:1145-1150.
14. Dalton S.O., Laursen T.M., Mellemkjaer L., Johansen C., Mortensen P.B. Risk for cancer in parents of patients with schizophrenia. Am. J. Psychiatry 2004, 161:903-908.
15. DeLisi L.E., Hoff A.L., Neale C., Kushner M. Asymmetries in the superior temporal lobe in male and female first-episode schizophrenic patients: measures of the planum temporale and superior temporal gyrus by MRI. Schizophr. Res. 1994, 12:19-28.
16. Dent E.W., Barnes A.M., Tang F., Kalil K. Netrin-1 and semaphorin 3A promote or inhibit cortical axon branching, respectively, by reorganization of the cytoskeleton. J. Neurosci. 2004, 24:3002-3012.
17. Depienne C., Cincotta M., Billot S., Bouteiller D., Groppa S., Brochard V., Flamand C., Hubsch C., Meunier S., Giovannelli F., Klebe S., Corvol J.C., Vidailhet M., Brice A., Roze E. A novel DCC mutation and genetic heterogeneity in congenital mirror movements. Neurology 2011, 76:260-264.
18. Fazeli A., Dickinson S.L., Hermiston M.L., Tighe R.V., Steen R.G., Small C.G., Stoeckli E.T., Keino-Masu K., Masu M., Rayburn H., Simons J., Bronson R.T., Gordon J.I., Tessier-Lavigne M., Weinberg R.A. Phenotype of mice lacking functional Deleted in colorectal cancer (Dcc) gene. Nature 1997, 386:796-804.
19. Fearon E.R., Cho K.R., Nigro J.M., Kern S.E., Simons J.W., Ruppert J.M., Hamilton S.R., Preisinger A.C., Thomas G., Kinzler K.W., et al. Identification of a chromosome 18q gene that is altered in colorectal cancers. Science 1990, 247:49-56.
20. Feinberg I. Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence?. J. Psychiatr. Res. 1982, 17:319-334.
21. Finger J.H., Bronson R.T., Harris B., Johnson K., Przyborski S.A., Ackerman S.L. The netrin 1 receptors Unc5h3 and Dcc are necessary at multiple choice points for the guidance of corticospinal tract axons. J. Neurosci. 2002, 22:10346-10356.
22. Flores C. Role of netrin-1 in the organization and function of the mesocorticolimbic dopamine system. J. Psychiatry Neurosci. 2011, 36:1-15.
23. Flores C., Manitt C., Rodaros D., Thompson K.M., Rajabi H., Luk K.C., Tritsch N.X., Sadikot A.F., Stewart J., Kennedy T.E. Netrin receptor deficient mice exhibit functional reorganization of dopaminergic systems and do not sensitize to amphetamine. Mol. Psychiatry 2005, 10:606-612.
24. Flor-Henry P. Psychosis and temporal lobe epilepsy: a controlled investigation. Epilepsia 1969, 10:363-395.
25. Gabriel S.B., Schaffner S.F., Nguyen H., Moore J.M., Roy J., Blumenstiel B., Higgins J., DeFelice M., Lochner A., Faggart M., Liu-Cordero S.N., Rotimi C., Adeyemo A., Cooper R., Ward R., Lander E.S., Daly M.J., Altshuler D. The structure of haplotype blocks in the human genome. Science 2002, 296:2225-2229.
26. Galaburda A.M., Geschwind N. Anatomical asymmetries in the adult and developing brain and their implications for function. Adv. Pediatr. 1981, 28:271-292.
27. Geschwind N., Levitsky W. Human brain: left-right asymmetries in temporal speech region. Science 1968, 161:186-187.
28. Goldacre M.J., Kurina L.M., Wotton C.J., Yeates D., Seagroat V. Schizophrenia and cancer: an epidemiological study. Br. J. Psychiatry 2005, 187:334-338.
29. Grant A., Hoops D., Labelle-Dumais C., Prevost M., Rajabi H., Kolb B., Stewart J., Arvanitogiannis A., Flores C. Netrin-1 receptor-deficient mice show enhanced mesocortical dopamine transmission and blunted behavioural responses to amphetamine. Eur. J. Neurosci. 2007, 26:3215-3228.
30. Grant A., Speed Z., Labelle-Dumais C., Flores C. Post-pubertal emergence of a dopamine phenotype in netrin-1 receptor-deficient mice. Eur. J. Neurosci. 2009, 30:1318-1328.
31. Grillon C., Ameli R., Charney D.S., Krystal J., Braff D. Startle gating deficits occur across prepulse intensities in schizophrenic patients. Biol. Psychiatry 1992, 32:939-943.
32. Grinshpoon A., Barchana M., Ponizovsky A., Lipshitz I., Nahon D., Tal O., Weizman A., Levav I. Cancer in schizophrenia: is the risk higher or lower?. Schizophr. Res. 2005, 73:333-341.
33. Harrison P.J., Weinberger D.R. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol. Psychiatry 2005, 10:40-68. image 45.
34. Howes O.D., Kapur S. The dopamine hypothesis of schizophrenia: version III-the final common pathway. Schizophr. Bull. 2009, 35:549-562.
35. Hutchins B.I., Kalil K. Differential outgrowth of axons and their branches is regulated by localized calcium transients. J. Neurosci. 2008, 28:143-153.
36. Impagnatiello F., Guidotti A.R., Pesold C., Dwivedi Y., Caruncho H., Pisu M.G., Uzunov D.P., Smalheiser N.R., Davis J.M., Pandey G.N., Pappas G.D., Tueting P., Sharma R.P., Costa E. A decrease of reelin expression as a putative vulnerability factor in schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:15718-15723.
37. Jaaro-Peled H., Hayashi-Takagi A., Seshadri S., Kamiya A., Brandon N.J., Sawa A. Neurodevelopmental mechanisms of schizophrenia: understanding disturbed postnatal brain maturation through neuregulin-1-ErbB4 and DISC1. Trends Neurosci. 2009, 32:485-495.
38. Kegeles L.S., Abi-Dargham A., Frankle W.G., Gil R., Cooper T.B., Slifstein M., Hwang D.R., Huang Y., Haber S.N., Laruelle M. Increased synaptic dopamine function in associative regions of the striatum in schizophrenia. Arch. Gen. Psychiatry 2010, 67:231-239.
39. Keino-Masu K., Masu M., Hinck L., Leonardo E.D., Chan S.S., Culotti J.G., Tessier-Lavigne M. Deleted in Colorectal Cancer (DCC) encodes a netrin receptor. Cell 1996, 87:175-185.
40. Laruelle M., Abi-Dargham A., van Dyck C.H., Gil R., D'Souza C.D., Erdos J., McCance E., Rosenblatt W., Fingado C., Zoghbi S.S., Baldwin R.M., Seibyl J.P., Krystal J.H., Charney D.S., Innis R.B. Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:9235-9240.
41. Levav I., Lipshitz I., Novikov I., Pugachova I., Kohn R., Barchana M., Ponizovsky A., Werner H. Cancer risk among parents and siblings of patients with schizophrenia. Br. J. Psychiatry 2007, 190:156-161.
42. Li X., Branch C.A., Ardekani B.A., Bertisch H., Hicks C., DeLisi L.E. fMRI study of language activation in schizophrenia, schizoaffective disorder and in individuals genetically at high risk. Schizophr. Res. 2007, 96:14-24.
43. Lichtermann D., Ekelund J., Pukkala E., Tanskanen A., Lonnqvist J. Incidence of cancer among persons with schizophrenia and their relatives. Arch. Gen. Psychiatry 2001, 58:573-578.
44. Lim Y.S., Mallapur S., Kao G., Ren X.C., Wadsworth W.G. Netrin UNC-6 and the regulation of branching and extension of motoneuron axons from the ventral nerve cord of Caenorhabditis elegans. J. Neurosci. 1999, 19:7048-7056.
45. Manitt C., Nikolakopoulou A.M., Almario D.R., Nguyen S.A., Cohen-Cory S. Netrin participates in the development of retinotectal synaptic connectivity by modulating axon arborization and synapse formation in the developing brain. J. Neurosci. 2009, 29:11065-11077.
46. Manitt C., Mimee A., Eng C., Pokinko M., Stroh T., Cooper H.M., Kolb B., Flores C. The netrin receptor DCC is required in the pubertal organization of mesocortical dopamine circuitry. J. Neurosci. 2011, 31:8381-8394.
47. McGlashan T.H., Hoffman R.E. Schizophrenia as a disorder of developmentally reduced synaptic connectivity. Arch. Gen. Psychiatry 2000, 57:637-648.
48. Mehlen P., Fearon E.R. Role of the dependence receptor DCC in colorectal cancer pathogenesis. J. Clin. Oncol. 2004, 22:3420-3428.
49. Mei L., Xiong W.C. Neuregulin 1 in neural development, synaptic plasticity and schizophrenia. Nat. Rev. Neurosci. 2008, 9:437-452.
50. Millar J.K., Wilson-Annan J.C., Anderson S., Christie S., Taylor M.S., Semple C.A., Devon R.S., St Clair D.M., Muir W.J., Blackwood D.H., Porteous D.J. Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum. Mol. Genet. 2000, 9:1415-1423.
51. Mortensen P.B. The occurrence of cancer in first admitted schizophrenic patients. Schizophr. Res. 1994, 12:185-194.
52. Oertel V., Knoche C., Rotarska-Jagiela A., Schonmeyer R., Lindner M., van de Ven V., Haenschel C., Uhlhaas P., Maurer K., Linden D.E. Reduced laterality as a trait marker of schizophrenia-evidence from structural and functional neuroimaging. J. Neurosci. 2010, 30:2289-2299.
53. Petty R.G. Structural asymmetries of the human brain and their disturbance in schizophrenia. Schizophr. Bull. 1999, 25:121-139.
54. Ross C.A., Margolis R.L., Reading S.A., Pletnikov M., Coyle J.T. Neurobiology of schizophrenia. Neuron 2006, 52:139-153.
55. Selemon L.D., Goldman-Rakic P.S. The reduced neuropil hypothesis: a circuit based model of schizophrenia. Biol. Psychiatry 1999, 45:17-25.
56. Shirakawa O., Kitamura N., Lin X.H., Hashimoto T., Maeda K. Abnormal neurochemical asymmetry in the temporal lobe of schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 2001, 25:867-877.
57. Sommer I.E., Ramsey N.F., Mandl R.C., van Oel C.J., Kahn R.S. Language activation in monozygotic twins discordant for schizophrenia. Br. J. Psychiatry 2004, 184:128-135.
58. Spear L.P. The adolescent brain and age-related behavioral manifestations. Neurosci. Biobehav. Rev. 2000, 24:417-463.
59. Srour M., Riviere J.B., Pham J.M., Dube M.P., Girard S., Morin S., Dion P.A., Asselin G., Rochefort D., Hince P., Diab S., Sharafaddinzadeh N., Chouinard S., Theoret H., Charron F., Rouleau G.A. Mutations in DCC cause congenital mirror movements. Science 2010, 328:592-595.
60. Stefansson H., Sigurdsson E., Steinthorsdottir V., Bjornsdottir S., Sigmundsson T., Ghosh S., Brynjolfsson J., Gunnarsdottir S., Ivarsson O., Chou T.T., Hjaltason O., Birgisdottir B., Jonsson H., Gudnadottir V.G., Gudmundsdottir E., Bjornsson A., Ingvarsson B., Ingason A., Sigfusson S., Hardardottir H., Harvey R.P., Lai D., Zhou M., Brunner D., Mutel V., Gonzalo A., Lemke G., Sainz J., Johannesson G., Andresson T., Gudbjartsson D., Manolescu A., Frigge M.L., Gurney M.E., Kong A., Gulcher J.R., Petursson H., Stefansson K. Neuregulin 1 and susceptibility to schizophrenia. Am. J. Hum. Genet. 2002, 71:877-892.
61. Straub R.E., Jiang Y., MacLean C.J., Ma Y., Webb B.T., Myakishev M.V., Harris-Kerr C., Wormley B., Sadek H., Kadambi B., Cesare A.J., Gibberman A., Wang X., O'Neill F.A., Walsh D., Kendler K.S. Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. Am. J. Hum. Genet. 2002, 71:337-348.
62. Tang F., Kalil K. Netrin-1 induces axon branching in developing cortical neurons by frequency-dependent calcium signaling pathways. J. Neurosci. 2005, 25:6702-6715.
63. Tseng K.Y., Chambers R.A., Lipska B.K. The neonatal ventral hippocampal lesion as a heuristic neurodevelopmental model of schizophrenia. Behav. Brain Res. 2009, 204:295-305.
64. Uhlhaas P.J., Singer W. The development of neural synchrony and large-scale cortical networks during adolescence: relevance for the pathophysiology of schizophrenia and neurodevelopmental hypothesis. Schizophr. Bull. 2011, 37:514-523.
65. Vogelstein B., Fearon E.R., Hamilton S.R., Kern S.E., Preisinger A.C., Leppert M., Nakamura Y., White R., Smits A.M., Bos J.L. Genetic alterations during colorectal-tumor development. N. Engl. J. Med. 1988, 319:525-532.
66. Weinberger D.R. Implications of normal brain development for the pathogenesis of schizophrenia. Arch. Gen. Psychiatry 1987, 44:660-669.
67. Whyte M.C., Whalley H.C., Simonotto E., Flett S., Shillcock R., Marshall I., Goddard N.H., Johnstone E.C., Lawrie S.M. Event-related fMRI of word classification and successful word recognition in subjects at genetically enhanced risk of schizophrenia. Psychol. Med. 2006, 36:1427-1439.
68. Xie X., Lu J., Kulbokas E.J., Golub T.R., Mootha V., Lindblad-Toh K., Lander E.S., Kellis M. Systematic discovery of regulatory motifs in human promoters and 3' UTRs by comparison of several mammals. Nature 2005, 434:338-345.
69. Yetnikoff L., Labelle-Dumais C., Flores C. Regulation of netrin-1 receptors by amphetamine in the adult brain. Neuroscience 2007, 150:764-773.
70. Yetnikoff L., Eng C., Benning S., Flores C. Netrin-1 receptor in the ventral tegmental area is required for sensitization to amphetamine. Eur. J. Neurosci. 2010, 31:1292-1302.